Amadix is a biotechnology company focused on the development and commercialization of diagnostic tools for personalized oncology treatment.
Amadix has raised €5.7M across 3 funding rounds from 2 investors, most recently a Grant round in Jan 2022. Based in Madrid, Spain; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2022-01-19 | Grant | €2.5M | European Innovation Council (EIC) | View deal → |
| 2019-10-01 | Other | €1.2M | The Crowd Angel | View deal → |
| 2013-02-01 | Other | €2.0M | — | View deal → |
